Scarica l'app Stockscreener
3.21
0.31%
-0.01
Dopo l'orario di chiusura:
3.21
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVXL Giù?
Forum
Previsione
Frazionamento azionario
Anavex Life Sciences Corp Borsa (AVXL) Ultime notizie
Anavex Urges Shareholders to Back Six Director Nominees Ahead of 2026 Annual Meeting - Yahoo Finance
Form 8K Anavex Life Sciences Corp For: 17 August By Investing.com - Investing.com India
Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees - manilatimes.net
Six Anavex Director Nominees Face a Sept. 24 Vote—What Sets Them Apart? - Stock Titan
Promising Penny Stocks To Consider In August 2026 - Sahm
(AVXL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Anavex Life Sciences Corp (AVXL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anavex Life Sciences Files Proxy, Urges Director Support - The Globe and Mail
Anavex Life Sciences Corp. (NASDAQ:AVXL) Receives Consensus Rating of "Hold" from Analysts - marketbeat.com
Anavex urges shareholders to back board slate amid proxy fight By Investing.com - Investing.com UK
Anavex Life Sciences files definitive proxy, urges vote for six director nominees ahead of Sept. 24 meeting - TradingView
Anavex Life Sciences Faces September Board Vote as Blarcamesine Regulatory Strategy Advances - Yahoo Finance
Anavex urges shareholders to back board slate amid proxy fight - Investing.com
Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders - manilatimes.net
Anavex Life Sciences Files Definitive Proxy Statement and Urges Stockholders to Vote for All Six Director Nominees on WHITE Card - Quiver Quantitative
Anavex Life Sciences Corp Solicits Proxies from Shareholders - marketscreener.com
Anavex Life Sciences (NASDAQ:AVXL) Stock Crosses Above 50-Day Moving AverageWhat's Next? - marketbeat.com
Anavex Life Sciences (NASDAQ: AVXL) delays two 2026 quarterly SEC reports - Stock Titan
Anavex Life Sciences Corp (AVXL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AVXL Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
Anavex Life Sciences Corp expected to post a loss of 8 cents a shareEarnings Preview - TradingView
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 509% Upside in Biotech - DirectorsTalk Interviews
Anavex Life Sciences Corp. Revenue Breakdown – NASDAQ:AVXL - TradingView
Anavex Life Sciences (NASDAQ:AVXL) Rallies Today on clinical-stage momentum - Kalkine Media
Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation - anavex.com
Press Release: Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation - moomoo.com
Weekly Recap: IND filing for blarcamesine and Q2 loss, cash runway - TradingView
[PREC14A] ANAVEX LIFE SCIENCES CORP. Preliminary Contested Proxy Statement - Stock Titan
Vanguard Capital Management (NASDAQ: AVXL) discloses 5.03% beneficial stake in Anavex - Stock Titan
Anavex Life Sciences: Fiscal Q2 Earnings Snapshot - king5.com
Anavex Life Sciences (NASDAQ:AVXL) Releases Earnings Results, Beats Expectations By $0.01 EPS - marketbeat.com
Anavex Life Sciences Corp (AVXL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Anavex Life Sciences Corp (AVXL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anavex Life Sciences Corp (AVXL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anavex Life Sciences Corp (AVXL) Balance Sheet - TradingKey
Anavex Life Sciences Corp (AVXL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AVXL|Anavex Life Sciences Corp|Price:2.400|Chg%:-0.080 - TradingKey
Anavex Life Sciences Corp (AVXL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anavex Life Sciences Corp (AVXL) Income Statement - TradingKey
AVXL|Anavex Life Sciences Corp|Price:2.532|Chg%:+0.032 - TradingKey
Anavex Life Sciences Corp. Revenue Breakdown – SWB:12X1 - TradingView
TradingKey - TradingKey
PVG targets full board replacement at Anavex Life Sciences (NASDAQ: AVXL) - Stock Titan
Trading Systems Reacting to (AVXL) Volatility - Stock Traders Daily
Anavex Submits Nasdaq Compliance Plan After Filing Delay - The Globe and Mail
Anavex Life Sciences Submits Plan to Regain Compliance With Nasdaq Timely Filing Rule - marketscreener.com
Anavex Life Sciences submits compliance plan to Nasdaq after 10-Q delay - TradingView
Anavex Life Sciences Corp. (NASDAQ:AVXL) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Axel Paeger Net Worth (2026) - GuruFocus
CNXU Stock Price and Chart — NASDAQ:CNXU - TradingView
AVXL Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock HigherRevenue Growth Outlook - dars.gov.et
Second Circuit Holds that Delayed, Market-Tracking Stock Drop Dooms Loss Causation - Jones Day
Anavex Life Sciences (AVXL) Jumps 6.98% as Biotech Rally Tests Key Resistance at $2.90TRIN Signal - dars.gov.et
Spotlight On Aldeyra Therapeutics And 2 Other Prominent Penny Stocks - Sahm
CEO transition and delayed SEC filing put Anavex (AVXL) leadership changes in focus - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
How Anavex Life Sciences Corp. (AVXL) Affects Rotational Strategy Timing - Stock Traders Daily
Anavex Life Sciences Corp. (AVXL) Investigation: Bronstein, Gewir - The National Law Review
Anavex Life Sciences Corp.(NasdaqGS: AVXL) added to Russell 2000 Value Benchmark - marketscreener.com
Anavex Life Sciences Corp.(NasdaqGS:AVXL) added to Russell Microcap Value Benchmark Index - marketscreener.com
Anavex Life Sciences: Waiting On Validation As Blarcamesine Shows Some Promise - Seeking Alpha
AVXL Forecast — Price Target — Prediction for 2027 - TradingView
1.80%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):